gimli

KOVAI stock AI analysis

KOVAI Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

KOVAI MEDICAL CENTER & HO is a small-cap stock in Healthcare. This Gimli page shows the latest available KOVAI price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive KOVAI stock page

Price

₹5,887.50

1W return

+0.44%

1M return

-1.77%

3M return

+0.94%

6M return

+4.06%

1Y return

n/a

Market cap

₹6,442.28 cr

25.50

4.88

ROE

+21.01%

ROCE

+23.06%

RSI

47.51

Turnover

₹2.06 cr

Why it can matter in screens

Momentum: KOVAI is below 50DMA, below 200DMA; RSI is 47.51.
Returns: 1D +0.24%, 1W +0.44%, 1M -1.77%, 3M +0.94%, 1Y n/a.
Trend levels: 52W high ₹6,444.00, 52W low ₹5,275.50, off high -8.64%.
Liquidity: latest turnover is ₹2.06 cr; volume vs 20D is +0.83%.
Valuation/profitability: PE 25.50, PB 4.88, ROE +21.01%, ROCE +23.06%.
Growth: 3Y sales CAGR +18.24%, 3Y profit CAGR +28.29%.

Quick Answers

What is the latest KOVAI stock price?

The latest stored price for KOVAI is Rs 5,887.50 as of 2026-11-03.

Is KOVAI above its 50DMA and 200DMA?

KOVAI is below 50DMA, below 200DMA. The latest 50DMA is 6,000.82 and the latest 200DMA is n/a.

What are KOVAI PE, ROE and ROCE?

KOVAI has PE 25.50, ROE +21.01%, and ROCE +23.06% in Gimli's latest available snapshot.

How has KOVAI performed recently?

KOVAI has returned -1.77% over 1 month, +0.94% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-06-30	438.65 cr	131.28 cr	69.09 cr	63.14
2026-03-31	413.20 cr	119.05 cr	59.69 cr	54.55
2025-12-31	406.62 cr	123.16 cr	65.02 cr	59.42
2025-09-30	390.74 cr	113.41 cr	58.86 cr	53.79
2025-06-30	373.59 cr	111.49 cr	57.23 cr	52.30
2025-03-31	356.64 cr	107.48 cr	54.70 cr	49.99
2024-12-31	354.70 cr	108.91 cr	57.80 cr	52.83
2024-09-30	n/a	n/a	n/a	46.32

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	1,584.15 cr	467.10 cr	244.46 cr	223.41
2025-03-31	1,369.74 cr	407.82 cr	208.95 cr	190.95
2024-03-31	1,133.84 cr	362.48 cr	179.73 cr	164.25
2023-03-31	958.19 cr	284.32 cr	115.77 cr	105.80
2022-03-31	917.82 cr	269.34 cr	104.26 cr	95.28

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	2,066.08 cr	63.72 cr	402.75 cr	1,319.27 cr
2025-03-31	1,799.91 cr	14.30 cr	415.34 cr	1,086.16 cr
2024-03-31	1,438.23 cr	59.60 cr	310.36 cr	888.54 cr
2023-03-31	1,438.12 cr	17.95 cr	510.91 cr	719.04 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	361.83 cr	109.88 cr	n/a
2025-03-31	352.91 cr	-0.18 cr	n/a
2024-03-31	344.13 cr	205.71 cr	n/a
2023-03-31	262.91 cr	135.52 cr	n/a
2022-03-31	n/a	n/a	n/a

Shareholding Trend

No recent data available.

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	424,658.30 cr	35.053345	+15.50%	+3.72%
DIVISLAB	DIVI S LABORATORIES LTD	267,167.60 cr	91.684145	+18.37%	+47.91%
TORNTPHARM	TORRENT PHARMACEUTICALS L	157,377.11 cr	74.094685	+16.87%	+28.16%
LAURUSLABS	LAURUS LABS LIMITED	125,408.69 cr	114.827348	+21.77%	+138.16%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	124,833.39 cr	27.818646	+16.04%	+26.46%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	121,354.29 cr	57.614911	+22.62%	+7.87%
DRREDDY	DR. REDDY S LABORATORIES	113,923.95 cr	40.698752	+7.80%	+14.41%
CIPLA	CIPLA LTD	112,841.65 cr	38.950805	+8.80%	-7.58%

Try these prompts

Analyze KOVAI MEDICAL CENTER & HO with valuation, momentum and industry peers
Compare KOVAI with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-11-03. Not investment advice.